Arrowhead Pharma (ARWR) PT Raised to $62 at Piper Sandler
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.39 --0%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 20
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 20
Join SI Premium – FREE
Piper Sandler analyst Edward A. Tenthoff raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $62.00 (from $59.00) while maintaining a Overweight rating.
You May Also Be Interested In
- AppLovin Corp (APP) PT Lowered to $510 at Evercore ISI, 'Taking a More Cautious Q4/FY27 View'
- UBS Upgrades Hercules Capital Inc (HTGC) to Buy
- China Resources Beverage (2460:HK) PT Lowered to HK$7.90 at CLSA
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
